Streetbeat News

Stock Prices

BABA

GEN

GLD

HOOD

NET

NVDA

QQQ

TSLA

TTWO

Swaggy Stocks has listed the top 10 trending stocks on WallStreetBets as of December 5, 2023. The stocks include NVIDIA Corporation (NVDA), Cloudflare, Inc. (NET), GameStop Corp. (GEN), Take-Two Interactive Software, Inc. (TTWO), C3.ai, Inc. (AI), Tesla, Inc. (TSLA), Barrick Gold Corporation (GLD), Robinhood Markets, Inc. (HOOD), Alibaba Group Holding Limited (BABA), and Invesco QQQ Trust (QQQ).

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 2:27 pm

RIVN

TSLA

Tesla Inc (TSLA) and Rivian Automotive (RIVN) are redefining automotive concepts with the delivery of Tesla's Cybertruck and Rivian's opening of its flagship store in a historic theater. Tesla's Cybertruck, with its unique design, enters the lucrative pickup segment, while Rivian's store aims to create a unique retail experience. The electric pickup market is growing, with Rivian and Ford's (F) electric pickups seeing sales increases. General Motors (GM) plans to challenge Tesla with more affordable EV models and aims to sell 1 million EVs by 2025.

Portfolio Pulse from Upwallstreet

December 05, 2023 | 2:27 pm

CVS

PBJ

On CNBC's 'Halftime Report Final Trades,' experts shared their picks including U.S. 1 Year Treasury Bill, CVS Health Corporation, Morgan Stanley, and Invesco Food & Beverage ETF. CVS Health reported a 10.6% increase in Q3 sales, beating estimates, and is set for Investor Day on Dec. 5, 2023. Morgan Stanley appointed a new CEO effective Jan. 1. CVS Health, Morgan Stanley, and Invesco Food & Beverage ETF all saw positive price action on Monday.

Portfolio Pulse from Lisa Levin

December 05, 2023 | 2:25 pm

Kroger Company (NYSE:KR) reported Q3 FY23 sales of $33.96 billion, slightly down by 0.7% YoY but above analyst estimates of $33.92 billion. Adjusted EPS was 95 cents, beating the 91 cents consensus. Kroger's annual dividend yield is 2.60%, with a quarterly dividend of 29 cents per share. To earn $500 monthly from dividends, an investment of approximately $231,033 or 5,172 shares is needed. The article also explains how dividend yield is calculated and its dependence on stock price and dividend payments. KR shares rose 0.2% to close at $44.67 on Monday.

Portfolio Pulse from Lisa Levin

December 05, 2023 | 2:24 pm

IBIO

iBio Inc. has announced the pricing of a $4.5 million public offering, which has led to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 2:24 pm

GLBE

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on Global E Online (NASDAQ: GLBE) and maintained a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 2:23 pm

CMND

Clearmind Medicine's stock is trading higher following the announcement of positive results in its cocaine addiction treatment study.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 2:23 pm

HOV

Hovnanian Enterprises (NYSE:HOV) reported a significant increase in Q4 earnings per share (EPS) to $13.05, up 80.25% from $7.24 in the same quarter last year. Sales saw a marginal increase to $887.03M from $886.79M YoY.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 2:22 pm

AAPL

BLK

EADSY

ERIC

IBM

META

MMSI

MSFT

MSTR

NIO

TSLA

Cryptocurrencies Bitcoin, Ethereum, and Dogecoin experienced a spike due to 'panic buying' and a weak dollar. BlackRock received seed funding for a Bitcoin ETF, and MicroStrategy profited as Bitcoin rallied. In Brazil, legislation drafted by ChatGPT was passed unanimously. In the US, stocks like Merit Medical Systems moved lower in pre-market, while investor sentiment remained in the 'greed' zone. Tech companies like IBM, Meta, and Microsoft announced significant developments. Electric vehicle companies like Nio, Tesla, and Ford reported on sales and legal challenges. General Motors and Dave & Buster's faced business hurdles, while Ericsson secured a major deal. Airbus is close to its 2023 delivery target.

Portfolio Pulse from Akanksha Bakshi

December 05, 2023 | 2:21 pm

ALLR

Allarity Therapeutics' stock (ALLR) is trading higher following the announcement of positive initial results from its Phase 2 clinical trial for stenoparib in advanced ovarian cancer.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 2:21 pm